Professional Documents
Culture Documents
Xylose
Xylose
Xylose
IMPURITIES
Specified impurities : A.
Other detectable impurities (the following substances would, C5H10O5 Mr 150.1
if present at a sufficient level, be detected by one or other of [58-86-6]
the tests in the monograph. They are limited by the general
acceptance criterion for other/unspecified impurities and/or DEFINITION
by the general monograph Substances for pharmaceutical use D-Xylopyranose.
(2034). It is therefore not necessary to identify these impurities
for demonstration of compliance. See also 5.10. Control of CHARACTERS
impurities in substances for pharmaceutical use) : B, C, D, E, F. Appearance : white or almost white, crystalline powder or
colourless needles.
Solubility : freely soluble in water, soluble in hot ethanol
(96 per cent).
IDENTIFICATION
First identification : A.
Second identification : B, C.
A. N-(2-aminoethyl)-2-[4-(1,1-dimethylethyl)-2,6- A. Infrared absorption spectrophotometry (2.2.24).
dimethylphenyl]acetamide, Preparation : discs.
Comparison : xylose CRS.
B. Thin-layer chromatography (2.2.27).
Solvent mixture : water R, methanol R (2:3 V/V).
Test solution. Dissolve 10 mg of the substance to be
examined in the solvent mixture and dilute to 20 mL with
the solvent mixture.
Reference solution (a). Dissolve 10 mg of xylose CRS in
B. 2-(chloromethyl)-5-(1,1-dimethylethyl)-1,3- the solvent mixture and dilute to 20 mL with the solvent
dimethylbenzene, mixture.
General Notices (1) apply to all monographs and other texts 4411
www.webofpharma.com